Novavax Outperforms Rivals After FDA Panel Backs Updated Covid Shots
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- PFE
- MRNA
- NVAX
Vaccine stocks rose Wednesday after a experts recommended including an omicron-fighting component in updated Covid boosters this fall.